James M. Shultz, MS, PhD; Siri Thoresen, PhD; Sandro Galea, MD, DrPH
JAMA. 2017;318(18):1753-1754. doi:10.1001/jama.2017.16420
This Viewpoint uses the October 2017 mass shooting in Las Vegas to discuss public health imperatives in the US firearm violence epidemic, including long-term treatment of nonfatally injured survivors, management of mental health sequelae for noninjured participants and their communities, and effective responses to commercial stakeholders who benefit from firearm sales at the expense of the public鈥檚 health.
-
Editorial
Death by Gun Violence鈥擜 Public Health Crisis
Howard Bauchner, MD; Frederick P. Rivara, MD, MPH; Robert O. Bonow, MD, MS; Neil M. Bressler, MD; Mary L. (Nora) Disis, MD; Stephan Heckers, MD; S. Andrew Josephson, MD; Melina R. Kibbe, MD; Jay F. Piccirillo, MD; Rita F. Redberg, MD, MSc; John S. Rhee, MD, MPH; June K. Robinson, MD
JAMA
Kenneth E. Warner, PhD; Steven A. Schroeder, MD
JAMA. 2017;318(18):1755-1756. doi:10.1001/jama.2017.14336
This Viewpoint discusses a new FDA regulatory plan to reduce the burden of smoking-related disease by requiring reduction of nicotine in combustible tobacco products beneath addicting levels and by encouraging innovations in novel reduced-risk nicotine products.
Hilary D. Marston, MD, MPH; Catharine I. Paules, MD; Anthony S. Fauci, MD
JAMA. 2017;318(18):1757-1758. doi:10.1001/jama.2017.15033
In this Viewpoint, Anthony Fauci and colleagues review rapid research responses to recent infectious disease outbreaks as a way of emphasizing the strategies and collaborations necessary to prepare for a next unknown pandemic.
Joshua M. Sharfstein, MD; Sule Gerovich, PhD; David Chin, MD
JAMA. 2017;318(18):1759-1760. doi:10.1001/jama.2017.14957
This Viewpoint discusses steps necessary to develop an all-payer hospital global budgeting system as one means to incentivize health systems to emphasize preventive care that reduces health service utilization and costs.